Is there a safe age for vaccinating infants with tetravalent rhesus-human reassortant rotavirus vaccine? [3]

Journal of Infectious Diseases

Volumn 194, Issue 12, 2006, Pages 1793-1794

  Gargiullo, Paul M ^a   Murphy, Trudy V ^b   Davis, Robert L ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ROTAVIRUS VACCINE; TETRAVALENT RHESUS HUMAN REASSORTANT ROTAVIRUS VACCINE;

AGE; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG SAFETY; HUMAN; INFANT; INTUSSUSCEPTION; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RISK; STATISTICAL ANALYSIS; VACCINATION; WORLD HEALTH ORGANIZATION;

AGE FACTORS; CASE-CONTROL STUDIES; HUMANS; INFANT; INFANT, NEWBORN; INTUSSUSCEPTION; RISK FACTORS; ROTAVIRUS VACCINES; VACCINES, ATTENUATED;

EID: 33845388297     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/509264     Document Type: Letter

References (6)

1. Murphy TV, Gargiullo PM, Massoudi MS, et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med 2001; 344:564-72.
2. Rothman KJ, Young-Xu Y, Arellano F. Age dependence of the relation between reassortant rotavirus vaccine (RotaShield) and intussusception [letter]. J Infect Dis 2006; 193:898.
3. Simonsen L, Taylor RJ, Elixhauser A, Viboud C, Kapikian AZ. Reply to Rothman et al. [letter]. J Infect Dis 2006; 193:898-9.
4. Simonsen L, Viboud C, Elixhauser A, Taylor RJ, Kapikian AZ. More on RotaShield and intussusception: the role of age at the time of vaccination. J Infect Dis 2005; 192(Suppl 1):S36-43.
5. Rosenberg PS, Katki H, Swanson CA, et al. Quantifying epidemiologic risk factors using non-parametric regression: model selection remains the greatest challenge. Stat Med 2003; 22:3369-81.
6. Global Advisory Committee on Vaccine Safety, 1-2 December 2005. Wkly Epidemiol Rec 2005; 81:15-19.